Publications by authors named "Cheng-Qiang Li"
Article Synopsis
- Nonalcoholic fatty liver disease (NAFLD) is a major global health issue that can worsen into serious liver conditions, with no current effective treatments available.
- A study using mouse models explored the effects of dapagliflozin, a new diabetes medication, in reducing liver damage associated with type 2 diabetes and NAFLD.
- Results showed that dapagliflozin significantly lowered blood sugar levels and improved liver function by decreasing certain liver proteins, suggesting it may be a promising treatment option for NAFLD linked to type 2 diabetes.
Background: Radiological manifestations of coronavirus disease 2019 (COVID-19) featured ground-glass opacities (GGOs), especially in the early stage, which might create confusion in differential diagnosis with early lung cancer. We aimed to specify the radiological characteristics of COVID-19 and early lung cancer and to unveil the discrepancy between them.
Methods: One hundred and fifty-seven COVID-19 patients and 374 early lung cancer patients from four hospitals in China were retrospectively enrolled.
Background: Autoantibodies against tumor associated antigens are highly related to cancer progression. Autoantibodies could serve as indicators of tumor burden, and have the potential to monitor the response of treatment and tumor recurrence. However, how the autoantibody repertoire changes in response to cancer treatment are largely unknown.
View Article and Find Full Text PDF